The Paris system of Reporting Urinary Cytology: Strengths and opportunities

The Paris system for reporting urinary cytopathology (TPS) was created to address inherent weaknesses inherent in the practice of urinary cytopathology. While urothelial cytology has always performed well at finding high grade, genetically unstable urothelial carcinoma, it performs poorly when it comes to detecting low‐grade urothelial neoplasia. TPS intends to improve the utility of urothelial cytology by focusing on what is important, high‐grade urothelial carcinoma. This article is a snapshot of the current state of TPS as it heads into its second edition. Successes are described and further developments are considered.